arsenic trioxide has been researched along with Cancer of Head in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, L; Liu, KJ; Xiang, B; Xue, B | 1 |
| Du, S; Gao, P; Li, Z; Liu, K; Zheng, J | 1 |
| An, L; Li, X; Yang, X | 1 |
| de Faria, GP; Dos Santos Ferreira, AC; Kwee, JK; Pereira, DL | 1 |
| Boyko-Fabian, M; Budach, V; Distel, L; Niehr, F; Tinhofer, I | 1 |
| Goux, D; Guillamin, M; Hamza-Chaffai, A; Khlifi, R; Sichel, F; Trabelsi, F | 1 |
| Chung, WH; Kim, SS; Kuh, HJ; Rhim, H; Sung, BH | 1 |
| Huilgol, NG | 1 |
| Hyun, JM; Jung, CW; Kim, BK; Kim, ES; Lee, YY; Park, WH; Seol, JG | 2 |
1 trial(s) available for arsenic trioxide and Cancer of Head
| Article | Year |
|---|---|
A phase I study to study arsenic trioxide with radiation and hyperthermia in advanced head and neck cancer.
Topics: Adult; Aged; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Head and Neck Neoplasms; Humans; Hyperthermia, Induced; Male; Middle Aged; Oxides; Radiation-Sensitizing Agents; Treatment Outcome | 2006 |
9 other study(ies) available for arsenic trioxide and Cancer of Head
| Article | Year |
|---|---|
Arsenic trioxide disturbs the LIS1/NDEL1/dynein microtubule dynamic complex by disrupting the CLIP170 zinc finger in head and neck cancer.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adult; Arsenic Trioxide; Carrier Proteins; Cell Cycle; Cell Line, Tumor; Cell Movement; Dyneins; Female; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Male; Microtubule-Associated Proteins; Microtubules; Middle Aged; Neoplasm Proteins | 2020 |
Differential anticancer activities of arsenic trioxide on head and neck cancer cells with different human papillomavirus status.
Topics: Aged; Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Mice, SCID; Middle Aged; Papillomaviridae; Papillomavirus Infections; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2018 |
Arsenic trioxide induced endoplasmic reticulum stress in laryngeal squamous cell line Hep-2 cells.
Topics: Activating Transcription Factor 4; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Squamous Cell; Cell Line, Tumor; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Eukaryotic Initiation Factor-2; Head and Neck Neoplasms; Heat-Shock Proteins; Humans; Laryngeal Neoplasms; Oxides; Squamous Cell Carcinoma of Head and Neck; Transcription Factor CHOP | 2014 |
Autophagy interplays with apoptosis and cell cycle regulation in the growth inhibiting effect of Trisenox in HEP-2, a laryngeal squamous cancer.
Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Autophagy; Carcinoma, Squamous Cell; Cell Cycle; Cell Line, Tumor; Cell Survival; Cisplatin; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Oxides; Reactive Oxygen Species; Squamous Cell Carcinoma of Head and Neck | 2015 |
Increased growth-inhibitory and cytotoxic activity of arsenic trioxide in head and neck carcinoma cells with functional p53 deficiency and resistance to EGFR blockade.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Squamous Cell; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA Breaks, Double-Stranded; Drug Resistance, Neoplasm; ErbB Receptors; Head and Neck Neoplasms; Humans; Oxides; Protein Kinase Inhibitors; Squamous Cell Carcinoma of Head and Neck; Tumor Suppressor Protein p53 | 2014 |
Cytotoxicity and genotoxicity effects of arsenic trioxide on SQ20B human laryngeal carcinoma cells.
Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Squamous Cell; Cell Line, Tumor; Comet Assay; DNA Damage; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Oxides; Squamous Cell Carcinoma of Head and Neck | 2017 |
Synergistic interaction between tetra-arsenic oxide and paclitaxel in human cancer cells in vitro.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arsenic Trioxide; Arsenicals; bcl-2-Associated X Protein; Blotting, Western; Caspase 3; Cisplatin; Drug Interactions; Drug Synergism; Female; Fluorouracil; Head and Neck Neoplasms; Humans; In Vitro Techniques; Inhibitory Concentration 50; Oxides; Paclitaxel; Poly(ADP-ribose) Polymerases; Stomach Neoplasms; Tubulin; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Uterine Cervical Neoplasms | 2009 |
Effect of arsenic trioxide on cell cycle arrest in head and neck cancer cell line PCI-1.
Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; CDC2 Protein Kinase; Cell Cycle; Cell Division; Cyclin B; Cyclin B1; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; G2 Phase; Growth Inhibitors; Head and Neck Neoplasms; Humans; Mitosis; Oxides; Tumor Cells, Cultured | 1999 |
Potential role of caspase-3 and -9 in arsenic trioxide-mediated apoptosis in PCI-1 head and neck cancer cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Apoptotic Protease-Activating Factor 1; Arsenic Trioxide; Arsenicals; Carcinoma, Squamous Cell; Caspase 3; Caspase 9; Caspases; Head and Neck Neoplasms; Humans; Membrane Potentials; Mice; Mitochondria; Oxides; Proteins; Tumor Cells, Cultured | 2001 |